Saurabh Gambhir elevated to Chief Strategy Officer (Global) at Cipla
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Union Health Minister calls for heightened vigilance, stronger public awareness campaigns, and district-specific action plans for the high-transmission season
CEO Stéphane Bancel framed the changes as essential to scaling the business
Suven has already begun planning a global Phase 3 registrational program for MDD based on the results
The newly approved treatment, SKINVIVE by JUVÉDERM, is now the first and only hyaluronic acid injectable cleared specifically for improving neck appearance
The launch event brought together policymakers, healthcare leaders, surgeons, and members of the medical fraternity to discuss the transformative role of robotic-assisted surgery
From a $10 billion bioeconomy to over $190 billion, indigenous CAR-T therapy, and a booming startup ecosystem highlight 12 years of transformation in India’s science and technology landscape
Veteran quality professional with over 20 years of industry experience to lead quality operations at Unit-4 API manufacturing facility
Subscribe To Our Newsletter & Stay Updated